262 related articles for article (PubMed ID: 29632299)
1. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.
Vijayakrishnan J; Studd J; Broderick P; Kinnersley B; Holroyd A; Law PJ; Kumar R; Allan JM; Harrison CJ; Moorman AV; Vora A; Roman E; Rachakonda S; Kinsey SE; Sheridan E; Thompson PD; Irving JA; Koehler R; Hoffmann P; Nöthen MM; Heilmann-Heimbach S; Jöckel KH; Easton DF; Pharaoh PDP; Dunning AM; Peto J; Canzian F; Swerdlow A; Eeles RA; Kote-Jarai Z; Muir K; Pashayan N; ; Greaves M; Zimmerman M; Bartram CR; Schrappe M; Stanulla M; Hemminki K; Houlston RS
Nat Commun; 2018 Apr; 9(1):1340. PubMed ID: 29632299
[TBL] [Abstract][Full Text] [Related]
2. Concordant B-cell precursor acute lymphoblastic leukemia in non-twinned siblings.
Pombo-de-Oliveira MS; Emerenciano M; Winn AP; Costa I; Mansur MB; Ford AM
Blood Cells Mol Dis; 2015 Jan; 54(1):110-5. PubMed ID: 25150625
[TBL] [Abstract][Full Text] [Related]
3. Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk.
Vijayakrishnan J; Qian M; Studd JB; Yang W; Kinnersley B; Law PJ; Broderick P; Raetz EA; Allan J; Pui CH; Vora A; Evans WE; Moorman A; Yeoh A; Yang W; Li C; Bartram CR; Mullighan CG; Zimmerman M; Hunger SP; Schrappe M; Relling MV; Stanulla M; Loh ML; Houlston RS; Yang JJ
Nat Commun; 2019 Nov; 10(1):5348. PubMed ID: 31767839
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of ETV6/RUNX1 and MLL aberrations in B-cell precursor acute lymphoblastic leukemia discloses a small subclass of BCP-ALL.
Amare Kadam PS; Raje GC; Pais AP; Banavali S
Cancer Genet Cytogenet; 2008 Apr; 182(1):27-32. PubMed ID: 18328947
[TBL] [Abstract][Full Text] [Related]
5. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
[TBL] [Abstract][Full Text] [Related]
6. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.
Migliorini G; Fiege B; Hosking FJ; Ma Y; Kumar R; Sherborne AL; da Silva Filho MI; Vijayakrishnan J; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson P; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Zimmermann M; Bartram CR; Schrappe M; Greaves M; Stanulla M; Hemminki K; Houlston RS
Blood; 2013 Nov; 122(19):3298-307. PubMed ID: 23996088
[TBL] [Abstract][Full Text] [Related]
7. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
[TBL] [Abstract][Full Text] [Related]
8. Low Frequency of ETV6-RUNX1 (t 12; 21) in Saudi Arabian Pediatric Acute Lymphoblastic Leukemia Patients: Association with Clinical Parameters and Early Remission.
Aljamaan K; Aljumah TK; Aloraibi S; Absar M; Iqbal Z
Asian Pac J Cancer Prev; 2015; 16(17):7523-7. PubMed ID: 26625756
[TBL] [Abstract][Full Text] [Related]
9. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
[TBL] [Abstract][Full Text] [Related]
10. Novel susceptibility variants at the
Qian M; Xu H; Perez-Andreu V; Roberts KG; Zhang H; Yang W; Zhang S; Zhao X; Smith C; Devidas M; Gastier-Foster JM; Raetz E; Larsen E; Burchard EG; Winick N; Bowman WP; Martin PL; Borowitz M; Wood B; Antillon-Klussmann F; Pui CH; Mullighan CG; Evans WE; Hunger SP; Relling MV; Loh ML; Yang JJ
Blood; 2019 Feb; 133(7):724-729. PubMed ID: 30510082
[TBL] [Abstract][Full Text] [Related]
11. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
[TBL] [Abstract][Full Text] [Related]
12. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
[TBL] [Abstract][Full Text] [Related]
13. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
[TBL] [Abstract][Full Text] [Related]
14. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
[TBL] [Abstract][Full Text] [Related]
15. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.
Ellinghaus E; Stanulla M; Richter G; Ellinghaus D; te Kronnie G; Cario G; Cazzaniga G; Horstmann M; Panzer Grümayer R; Cavé H; Trka J; Cinek O; Teigler-Schlegel A; ElSharawy A; Häsler R; Nebel A; Meissner B; Bartram T; Lescai F; Franceschi C; Giordan M; Nürnberg P; Heinzow B; Zimmermann M; Schreiber S; Schrappe M; Franke A
Leukemia; 2012 May; 26(5):902-9. PubMed ID: 22076464
[TBL] [Abstract][Full Text] [Related]
16. Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.
Barbosa TC; Oliveira E; Blunck CB; Maciel A; Bastos A; Bouzada H; Rouxinol ST; Mansur MB; Costa ES; Almeida CW; Emerenciano M
Cancer Genet; 2023 Aug; 276-277():40-42. PubMed ID: 37480760
[No Abstract] [Full Text] [Related]
17. Toward prevention of childhood ALL by early-life immune training.
Hauer J; Fischer U; Borkhardt A
Blood; 2021 Oct; 138(16):1412-1428. PubMed ID: 34010407
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia.
Usami I; Imamura T; Takahashi Y; Suenobu SI; Hasegawa D; Hashii Y; Deguchi T; Hori T; Shimada A; Kato K; Ito E; Moriya-Saito A; Kawasaki H; Hori H; Yumura-Yagi K; Hara J; Sato A; Horibe K;
Int J Hematol; 2019 Apr; 109(4):477-482. PubMed ID: 30689137
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.
Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV
Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
